カテゴリー： Market Monitor Global, 世界, 医療/バイオ

神経刺激装置の世界市場見通し2023年-2029年

◆英語タイトル：Neurostimulation Devices Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23FB2375）◆商品コード：MMG23FB2375
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年2月
◆ページ数：74
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界の神経刺激装置市場規模と予測を収録しています。・世界の神経刺激装置市場：売上、2018年-2023年、2024年-2029年
・世界の神経刺激装置市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の神経刺激装置市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「脊髄刺激（SCS）」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

神経刺激装置のグローバル主要企業は、Medtronic、Boston Scientific、Abbott、LivaNova、Nevro、NeuroPace、Beijing Pins、Synapse Biomedicalなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、神経刺激装置のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の神経刺激装置市場：タイプ別、2018年-2023年、2024年-2029年
世界の神経刺激装置市場：タイプ別市場シェア、2022年
・脊髄刺激（SCS）、胃電気刺激（GES）、脳深部刺激（DBS）、仙骨神経刺激（SNS）、迷走神経刺激（VNS）、その他

世界の神経刺激装置市場：用途別、2018年-2023年、2024年-2029年
世界の神経刺激装置市場：用途別市場シェア、2022年
・疼痛管理、パーキンソン病、尿失禁、便失禁、てんかん、胃不全麻痺、その他

世界の神経刺激装置市場：地域・国別、2018年-2023年、2024年-2029年
世界の神経刺激装置市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における神経刺激装置のグローバル売上、2018年-2023年
・主要企業における神経刺激装置のグローバル売上シェア、2022年
・主要企業における神経刺激装置のグローバル販売量、2018年-2023年
・主要企業における神経刺激装置のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Medtronic、Boston Scientific、Abbott、LivaNova、Nevro、NeuroPace、Beijing Pins、Synapse Biomedical

*************************************************************

・調査・分析レポートの概要
神経刺激装置市場の定義
市場セグメント
世界の神経刺激装置市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の神経刺激装置市場規模
世界の神経刺激装置市場規模：2022年 VS 2029年
世界の神経刺激装置市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの神経刺激装置の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の神経刺激装置製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：脊髄刺激（SCS）、胃電気刺激（GES）、脳深部刺激（DBS）、仙骨神経刺激（SNS）、迷走神経刺激（VNS）、その他
神経刺激装置のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：疼痛管理、パーキンソン病、尿失禁、便失禁、てんかん、胃不全麻痺、その他
神経刺激装置の用途別グローバル売上・予測

・地域別市場分析
地域別神経刺激装置市場規模 2022年と2029年
地域別神経刺激装置売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Medtronic、Boston Scientific、Abbott、LivaNova、Nevro、NeuroPace、Beijing Pins、Synapse Biomedical
...

Neurostimulation is a therapeutic activation of part of the nervous system using microelectrodes. The electrodes are used to interface with excitable tissue in order to either restore sensation, such as a cochlear implant for hearing, or control anorgan, such as a heart pacemaker.
Neurostimulation technology improves the life quality of those who are severely paralyzed or suffering from profound losses to various sense organs. It serves as the key part of neural prosthetics for hearing aids, artificial vision, artificial limbs, and brain-machine interfaces. In the case of neural stimulation, mostly an electrical stimulation is utilized and charge-balanced biphasic constant current waveforms of capacitive coupled charge injection approaches are adopted. Alternatively, the transcranial magnetic stimulation has been proposed as a non-invasive method in which a magnetic field causes neurostimulation.
Neurostimulation devices are implantable devices that help in the therapeutic activation of the nervous systems. These devices deliver electrical stimulation to the brain and nervous systems for the treatment of various types of neurological disorders such as pain, epilepsy, Parkinson’s disease, depression, obsessive-compulsive disorder, dystonia, and tremors. These devices target specific areas of the brain or spinal cord by blocking the pain messages before they reach the brain.
This report aims to provide a comprehensive presentation of the global market for Neurostimulation Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neurostimulation Devices. This report contains market size and forecasts of Neurostimulation Devices in global, including the following market information:
Global Neurostimulation Devices Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Neurostimulation Devices Market Sales, 2018-2023, 2024-2029, (Units)
Global top five Neurostimulation Devices companies in 2022 (%)
The global Neurostimulation Devices market was valued at US$ 6832.2 million in 2022 and is projected to reach US$ 14020 million by 2029, at a CAGR of 10.8% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Neurostimulation Devices key players include Medtronic, Boston Scientific, St. Jude Medical (Abbott), etc. Global top three manufacturers hold a share over 75%.
North America is the largest market, with a share over 40%, followed by China, and Europe, both have a share about 40 percent.
In terms of product, Spinal Cord Stimulation (SCS) is the largest segment, with a share over 55%. And in terms of application, the largest application is Pain Management, followed by Parkinson’s Disease, Epilepsy, Urinary and Fecal Incontinence, etc.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Neurostimulation Devices manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
[Total Market by Segment]
Global Neurostimulation Devices Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Neurostimulation Devices Market Segment Percentages, by Type, 2022 (%)
Spinal Cord Stimulation (SCS)
Gastric Electric Stimulation (GES)
Deep Brain Stimulation (DBS)
Sacral Nerve Stimulation (SNS)
Vagus Nerve Stimulation (VNS)
Other
Global Neurostimulation Devices Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Neurostimulation Devices Market Segment Percentages, by Application, 2022 (%)
Pain Management
Parkinson’s Disease
Urinary and Fecal Incontinence
Epilepsy
Gastroparesis
Other
Global Neurostimulation Devices Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Neurostimulation Devices Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Neurostimulation Devices revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Neurostimulation Devices revenues share in global market, 2022 (%)
Key companies Neurostimulation Devices sales in global market, 2018-2023 (Estimated), (Units)
Key companies Neurostimulation Devices sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Medtronic
Boston Scientific
Abbott
LivaNova
Nevro
NeuroPace
Beijing Pins
Synapse Biomedical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Neurostimulation Devices, market overview.
Chapter 2: Global Neurostimulation Devices market size in revenue and volume.
Chapter 3: Detailed analysis of Neurostimulation Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Neurostimulation Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Neurostimulation Devices capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Neurostimulation Devices Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Neurostimulation Devices Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Neurostimulation Devices Overall Market Size
2.1 Global Neurostimulation Devices Market Size: 2022 VS 2029
2.2 Global Neurostimulation Devices Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Neurostimulation Devices Sales: 2018-2029
3 Company Landscape
3.1 Top Neurostimulation Devices Players in Global Market
3.2 Top Global Neurostimulation Devices Companies Ranked by Revenue
3.3 Global Neurostimulation Devices Revenue by Companies
3.4 Global Neurostimulation Devices Sales by Companies
3.5 Global Neurostimulation Devices Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Neurostimulation Devices Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Neurostimulation Devices Product Type
3.8 Tier 1, Tier 2 and Tier 3 Neurostimulation Devices Players in Global Market
3.8.1 List of Global Tier 1 Neurostimulation Devices Companies
3.8.2 List of Global Tier 2 and Tier 3 Neurostimulation Devices Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Neurostimulation Devices Market Size Markets, 2022 & 2029
4.1.2 Spinal Cord Stimulation (SCS)
4.1.3 Gastric Electric Stimulation (GES)
4.1.4 Deep Brain Stimulation (DBS)
4.1.5 Sacral Nerve Stimulation (SNS)
4.1.6 Vagus Nerve Stimulation (VNS)
4.1.7 Other
4.2 By Type – Global Neurostimulation Devices Revenue & Forecasts
4.2.1 By Type – Global Neurostimulation Devices Revenue, 2018-2023
4.2.2 By Type – Global Neurostimulation Devices Revenue, 2024-2029
4.2.3 By Type – Global Neurostimulation Devices Revenue Market Share, 2018-2029
4.3 By Type – Global Neurostimulation Devices Sales & Forecasts
4.3.1 By Type – Global Neurostimulation Devices Sales, 2018-2023
4.3.2 By Type – Global Neurostimulation Devices Sales, 2024-2029
4.3.3 By Type – Global Neurostimulation Devices Sales Market Share, 2018-2029
4.4 By Type – Global Neurostimulation Devices Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Neurostimulation Devices Market Size, 2022 & 2029
5.1.2 Pain Management
5.1.3 Parkinson’s Disease
5.1.4 Urinary and Fecal Incontinence
5.1.5 Epilepsy
5.1.6 Gastroparesis
5.1.7 Other
5.2 By Application – Global Neurostimulation Devices Revenue & Forecasts
5.2.1 By Application – Global Neurostimulation Devices Revenue, 2018-2023
5.2.2 By Application – Global Neurostimulation Devices Revenue, 2024-2029
5.2.3 By Application – Global Neurostimulation Devices Revenue Market Share, 2018-2029
5.3 By Application – Global Neurostimulation Devices Sales & Forecasts
5.3.1 By Application – Global Neurostimulation Devices Sales, 2018-2023
5.3.2 By Application – Global Neurostimulation Devices Sales, 2024-2029
5.3.3 By Application – Global Neurostimulation Devices Sales Market Share, 2018-2029
5.4 By Application – Global Neurostimulation Devices Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Neurostimulation Devices Market Size, 2022 & 2029
6.2 By Region – Global Neurostimulation Devices Revenue & Forecasts
6.2.1 By Region – Global Neurostimulation Devices Revenue, 2018-2023
6.2.2 By Region – Global Neurostimulation Devices Revenue, 2024-2029
6.2.3 By Region – Global Neurostimulation Devices Revenue Market Share, 2018-2029
6.3 By Region – Global Neurostimulation Devices Sales & Forecasts
6.3.1 By Region – Global Neurostimulation Devices Sales, 2018-2023
6.3.2 By Region – Global Neurostimulation Devices Sales, 2024-2029
6.3.3 By Region – Global Neurostimulation Devices Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Neurostimulation Devices Revenue, 2018-2029
6.4.2 By Country – North America Neurostimulation Devices Sales, 2018-2029
6.4.3 US Neurostimulation Devices Market Size, 2018-2029
6.4.4 Canada Neurostimulation Devices Market Size, 2018-2029
6.4.5 Mexico Neurostimulation Devices Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Neurostimulation Devices Revenue, 2018-2029
6.5.2 By Country – Europe Neurostimulation Devices Sales, 2018-2029
6.5.3 Germany Neurostimulation Devices Market Size, 2018-2029
6.5.4 France Neurostimulation Devices Market Size, 2018-2029
6.5.5 U.K. Neurostimulation Devices Market Size, 2018-2029
6.5.6 Italy Neurostimulation Devices Market Size, 2018-2029
6.5.7 Russia Neurostimulation Devices Market Size, 2018-2029
6.5.8 Nordic Countries Neurostimulation Devices Market Size, 2018-2029
6.5.9 Benelux Neurostimulation Devices Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Neurostimulation Devices Revenue, 2018-2029
6.6.2 By Region – Asia Neurostimulation Devices Sales, 2018-2029
6.6.3 China Neurostimulation Devices Market Size, 2018-2029
6.6.4 Japan Neurostimulation Devices Market Size, 2018-2029
6.6.5 South Korea Neurostimulation Devices Market Size, 2018-2029
6.6.6 Southeast Asia Neurostimulation Devices Market Size, 2018-2029
6.6.7 India Neurostimulation Devices Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Neurostimulation Devices Revenue, 2018-2029
6.7.2 By Country – South America Neurostimulation Devices Sales, 2018-2029
6.7.3 Brazil Neurostimulation Devices Market Size, 2018-2029
6.7.4 Argentina Neurostimulation Devices Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Neurostimulation Devices Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Neurostimulation Devices Sales, 2018-2029
6.8.3 Turkey Neurostimulation Devices Market Size, 2018-2029
6.8.4 Israel Neurostimulation Devices Market Size, 2018-2029
6.8.5 Saudi Arabia Neurostimulation Devices Market Size, 2018-2029
6.8.6 UAE Neurostimulation Devices Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Medtronic
7.1.1 Medtronic Company Summary
7.1.2 Medtronic Business Overview
7.1.3 Medtronic Neurostimulation Devices Major Product Offerings
7.1.4 Medtronic Neurostimulation Devices Sales and Revenue in Global (2018-2023)
7.1.5 Medtronic Key News & Latest Developments
7.2 Boston Scientific
7.2.1 Boston Scientific Company Summary
7.2.2 Boston Scientific Business Overview
7.2.3 Boston Scientific Neurostimulation Devices Major Product Offerings
7.2.4 Boston Scientific Neurostimulation Devices Sales and Revenue in Global (2018-2023)
7.2.5 Boston Scientific Key News & Latest Developments
7.3 Abbott
7.3.1 Abbott Company Summary
7.3.2 Abbott Business Overview
7.3.3 Abbott Neurostimulation Devices Major Product Offerings
7.3.4 Abbott Neurostimulation Devices Sales and Revenue in Global (2018-2023)
7.3.5 Abbott Key News & Latest Developments
7.4 LivaNova
7.4.1 LivaNova Company Summary
7.4.2 LivaNova Business Overview
7.4.3 LivaNova Neurostimulation Devices Major Product Offerings
7.4.4 LivaNova Neurostimulation Devices Sales and Revenue in Global (2018-2023)
7.4.5 LivaNova Key News & Latest Developments
7.5 Nevro
7.5.1 Nevro Company Summary
7.5.2 Nevro Business Overview
7.5.3 Nevro Neurostimulation Devices Major Product Offerings
7.5.4 Nevro Neurostimulation Devices Sales and Revenue in Global (2018-2023)
7.5.5 Nevro Key News & Latest Developments
7.6 NeuroPace
7.6.1 NeuroPace Company Summary
7.6.2 NeuroPace Business Overview
7.6.3 NeuroPace Neurostimulation Devices Major Product Offerings
7.6.4 NeuroPace Neurostimulation Devices Sales and Revenue in Global (2018-2023)
7.6.5 NeuroPace Key News & Latest Developments
7.7 Beijing Pins
7.7.1 Beijing Pins Company Summary
7.7.2 Beijing Pins Business Overview
7.7.3 Beijing Pins Neurostimulation Devices Major Product Offerings
7.7.4 Beijing Pins Neurostimulation Devices Sales and Revenue in Global (2018-2023)
7.7.5 Beijing Pins Key News & Latest Developments
7.8 Synapse Biomedical
7.8.1 Synapse Biomedical Company Summary
7.8.2 Synapse Biomedical Business Overview
7.8.3 Synapse Biomedical Neurostimulation Devices Major Product Offerings
7.8.4 Synapse Biomedical Neurostimulation Devices Sales and Revenue in Global (2018-2023)
7.8.5 Synapse Biomedical Key News & Latest Developments
8 Global Neurostimulation Devices Production Capacity, Analysis
8.1 Global Neurostimulation Devices Production Capacity, 2018-2029
8.2 Neurostimulation Devices Production Capacity of Key Manufacturers in Global Market
8.3 Global Neurostimulation Devices Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Neurostimulation Devices Supply Chain Analysis
10.1 Neurostimulation Devices Industry Value Chain
10.2 Neurostimulation Devices Upstream Market
10.3 Neurostimulation Devices Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Neurostimulation Devices Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 神経刺激装置の世界市場見通し2023年-2029年(Neurostimulation Devices Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 心室補助装置の世界市場見通し2023年-2029年
  • ロービジョン補助デバイスの世界市場見通し2023年-2029年
  • 医療機器用3D印刷の世界市場見通し2023年-2029年
  • 呼吸装置の世界市場見通し2023年-2029年
  • 痔用治療器具の世界市場見通し2023年-2029年